Activists meet with Gilead and Abbott over access to second-line therapy
3 August 2006. Related: Treatment access.
2006
Data exclusivity: a new threat to affordable generic medicines
3 August 2006. Related: Treatment access.
Updated US perinatal guidelines (2006)
3 August 2006. Related: Guidelines.
Efficacy of treatment of acute hepatiitis C in patients with HIV infection
3 August 2006. Related: Hepatitis coinfection.
HIV transmission, the law and the work of the clinical team: draft recommendations for comment
3 August 2006. Related: Other news.
FDA adds last minute clause into package of patient reforms that protects pharmaceutical industry from litigation in cases of side effects
3 August 2006. Related: Other news.
Full journal articles with free access and online medical resources
3 August 2006. Related: On the web.
Advocacy campaign tools online
3 August 2006. Related: On the web.
Volume 7 Number 7/8 July/August 2006 PDF
1 August 2006. Related: PDFs.
Volume 7 Number 6 June 2006
30 June 2006. Related: Editorial.
7th International Workshop on Clinical Pharmacology of HIV Therapy, 20-22 April 2006, Lisbon
11 June 2006. Related: Conference reports.
Efavirenz levels above recommended upper target in 20% of African patients in Senegal
11 June 2006. Related: Conference reports, Antiretrovirals.
Lower dose of AZT provides adequate exposure in patients with low body weight
11 June 2006. Related: Conference reports, Antiretrovirals.
Pharmacokinetics for generic fixed dose combinations for children are comparable to the branded products
11 June 2006. Related: Conference reports, Paediatric care.
Caution against dividing adult FDCs (Triomune) for young children
11 June 2006. Related: Conference reports, Paediatric care.
University of Liverpool audit of paediatric TDM
11 June 2006. Related: Conference reports, Paediatric care.
Age-dependent pharmacokinetics of 3TC in children
11 June 2006. Related: Conference reports, Paediatric care.
Use of small sample drug level monitoring for paediatric PI concentrations
11 June 2006. Related: Conference reports, Paediatric care.
Intracellular and plasma measurements of AZT and 3TC and their metabolites in neonates
11 June 2006. Related: Conference reports, Paediatric care.
Effect of pregnancy on PK of protease inhibitors
11 June 2006. Related: Conference reports, Pregnancy.
Using enzyme inducers to reduce the half-life of nevirapine
11 June 2006. Related: Conference reports.
Relationship between nevirapine concentrations and virological failure in a clinical setting
11 June 2006. Related: Conference reports, PK and drug interactions.
Summary of drug interaction studies
11 June 2006. Related: Conference reports, PK and drug interactions.
Effects of ketoconazole and rifampin on TMC278
10 June 2006. Related: Conference reports, PK and drug interactions.
Brecanavir interaction study with ritonavir and atazanavir
10 June 2006. Related: Conference reports, PK and drug interactions.
Fixed-dose formulation of efavirenz/tenofovir/FTC bioequivalent to separate dosing
10 June 2006. Related: Conference reports, Antiretrovirals.
Saquinavir/r (1000/100mg) levels reduced when taken fasted and should be taken with food
10 June 2006. Related: Conference reports, Antiretrovirals.
Lack of food effect with Meltrex formulation of lopinavir/r
10 June 2006. Related: Conference reports, Antiretrovirals.
Food interaction reduces ddI intracellular absorption and supports requirement to take fasted
10 June 2006. Related: Conference reports, Antiretrovirals.
Conflicting results on how T-20 affects tipranavir
10 June 2006. Related: Conference reports, Antiretrovirals.
Autologous stem cells transplant (ASCT) in HIV-positive individuals with a relapsed non-Hodgkins lymphoma (NHL) or Hodgkins disease (HD)
10 June 2006. Related: Treatment strategies.
US adult treatment guidelines updated (May 2006)
10 June 2006. Related: Guidelines.
Draft BHIVA immunisation guidelines online (2006)
10 June 2006. Related: Guidelines.
ITPC publish updated report on access to treatment
10 June 2006. Related: Treatment access.
Protesters evicted from UN headquarters, New York
10 June 2006. Related: Treatment access.
Community opposition filed against tenofovir patent application in India
10 June 2006. Related: Treatment access.
Web resources for HIV-1 genotypic-resistance test interpretation
10 June 2006. Related: Drug resistance.
HIV linked to lower rifampin and ethambutol AUCs in TB cohort
10 June 2006. Related: TB coinfection.
LGV in the UK: almost 350 cases reported and still predominantly affecting HIV-positive gay men
10 June 2006. Related: Other news.
Conference abstracts and reports
10 June 2006. Related: On the web.
HIV InSite: new chapters
10 June 2006. Related: On the web.
PLoS Medicine articles
10 June 2006. Related: On the web.
New HIV vaccine website
10 June 2006. Related: On the web.
Volume 7 Number 6 June 2006 PDF
1 June 2006. Related: PDFs.
Volume 7 Number 5 May 2006
30 May 2006. Related: Editorial.
Letter from Sir Liam Donaldson to all Chief Executives of Primary Care Trusts and Strategic Health Authorities in England
24 May 2006. Related: Other news.
12th Annual Conference of the British HIV Association, 29 March-1 April 2006, Brighton
12 May 2006. Related: Conference reports.
HIV in the UK summaries from BHIVA 12th annual conference
12 May 2006. Related: Conference reports.
Primary care practice still fails to diagnose HIV patients from high-risk groups or with symptomatic acute infection
12 May 2006. Related: Conference reports.
Use of HLA-B*5701 genetic testing to reduce abacavir hypersensitivity reactions
12 May 2006. Related: Conference reports, Side effects.
Dosing rifabutin and lopinavir/r sub-optimal rifabutin levels reported in five patients dosed according to current guidelines
12 May 2006. Related: Conference reports, PK and drug interactions, TB coinfection.
Fatal seronegative visceral leishmaniasis in Portuguese patient
12 May 2006. Related: Conference reports, Coinfections and complications.
Awareness of PEP after sexual exposure (PEPSE)
12 May 2006. Related: Conference reports.
Final reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
12 May 2006. Related: Conference reports.
Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa
12 May 2006. Related: Conference reports, Side effects.
Adults in resource-limited settings are most likely to experience an HIV-associated Illness in the first three months from initiating therapy
12 May 2006. Related: Conference reports.
Causes of death in adults receiving ARV therapy in Senegal
12 May 2006. Related: Conference reports.
Rapid scale-up of treatment in Zambia delivered at primary health level
12 May 2006. Related: Conference reports.
The effect of HIV subtype on disease progression in Rakai, Uganda
12 May 2006. Related: Conference reports.
Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women
12 May 2006. Related: Conference reports, Women's health.
Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA
12 May 2006. Related: Conference reports, Women's health.
Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load
12 May 2006. Related: Conference reports, Women's health.
Once-daily FTC, ddI, and efavirenz in children and adolescents
12 May 2006. Related: Conference reports, Paediatric care.
Simplified triple NRTI regimen effective in vertically infected children: two years follow-up
12 May 2006. Related: Conference reports, Paediatric care.
Long-term clinical and biological outcomes in children vertically infected with HIV
12 May 2006. Related: Conference reports, Paediatric care.